Type 2 diabetes mellitus is a metabolic disease characterized by chronic hyperglycemia, which develops as a result of an increasing decrease in the production of insulin by pancreatic cells, and a violation of the interaction of insulin with tissue cells known as insulin resistance. The prevalence of chronic heart failure in patients with type 2 diabetes, as of December 2020, ranges from 24% to 40%. According to the Health Care Cost Institute (HCCI), a nonprofit organization, in 2016, the annual cost of insulin for a patient with type 2 diabetes was $5,705, which is almost twice as high as in…